Ribozyme deal

Ribozyme Pharmaceuticals Inc. Ribozyme and Warner-Lambert Co.'s Parke-Davis pharmaceutical research division extended their 1993 agreement to develop ribozyme-based drugs for osteoarthritis. The com...